Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma

Ofer Margalit; Shun Yu; Einat Shacham-Shmueli; Gal Strauss; Yu-Xiao Yang; Yaacov R Lawrence; Kim A Reiss; Talia Golan; Naama Halpern; Dan Aderka; Bruce Giantonio; Ronac Mamtani; Ben Boursi

doi:10.1007/s00432-022-04062-6

Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma

J Cancer Res Clin Oncol. 2022 Jul;148(7):1709. doi: 10.1007/s00432-022-04062-6.

Authors

Ofer Margalit^#^{1

2}, Shun Yu^#^{3

4}, Einat Shacham-Shmueli^{5

6}, Gal Strauss^{5

6}, Yu-Xiao Yang^{3

7}, Yaacov R Lawrence^{5

6

8}, Kim A Reiss⁸, Talia Golan^{5

6}, Naama Halpern^{5

6}, Dan Aderka^{5

6}, Bruce Giantonio⁹, Ronac Mamtani^{3

8}, Ben Boursi^{5

6

3}

Affiliations

¹ Institute of Oncology, Sheba Medical Center, Tel-Hashomer, 52621, Ramat Gan, Israel. ofer.margalit@sheba.health.gov.il.
² Tel-Aviv University, Tel-Aviv, Israel. ofer.margalit@sheba.health.gov.il.
³ Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Institute of Oncology, Sheba Medical Center, Tel-Hashomer, 52621, Ramat Gan, Israel.
⁶ Tel-Aviv University, Tel-Aviv, Israel.
⁷ Division of Gastroenterology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁸ Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
⁹ Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

^# Contributed equally.

PMID: 35652957
DOI: 10.1007/s00432-022-04062-6

No abstract available

Publication types

Published Erratum